adamantane has been researched along with Cognitive Dysfunction in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 5 (71.43) | 2.80 |
| Authors | Studies |
|---|---|
| Dudka, J; Gawrońska-Grzywacz, M; Herbet, M; Piątkowska-Chmiel, I; Popiołek, Ł | 1 |
| Benedet, AL; Chakravarty, M; Chamoun, M; Cuello, AC; Dickerson, BC; DuBois, JM; Farzin, S; Gauthier, S; Gilbert, TM; Guiot, MC; Hightower, BG; Hooker, JM; Hopewell, R; Hwang, H; Hyman, BT; Kang, MS; Kobayashi, E; Lax, E; Lussier, FZ; Massarweh, G; Mathotaarachchi, S; Mohaddes, S; Ng, KP; Pascoal, TA; Rosa-Neto, P; Salaciak, A; Savard, M; Schroeder, FA; Shin, M; Soucy, JP; Szyf, M; Therriault, J; Thomas, E; Tullo, S; Wang, C; Wey, HY; Zürcher, NR | 1 |
| Grieb, P; Rejdak, K | 1 |
| Apaijai, N; Chattipakorn, N; Chattipakorn, SC; Chunchai, T; Jaiwongkam, T; Kerdphoo, S; Pratchayasakul, W; Saiyasit, N; Sripetchwandee, J | 1 |
| Baazaoui, N; Dai, CL; Iqbal, K; Liu, F; Liu, Y; Tung, YC; Wei, W | 1 |
| Huang, M; Jiang, LF; Ma, QH; Mao, JL; Xu, WX | 1 |
| Chattipakorn, N; Chattipakorn, SC; Jaiwongkam, T; Jiang, C; Kerdphoo, S; Li, X; Liang, G; Pratchayasakul, W; Sa-Nguanmoo, P; Tanajak, P; Wang, X | 1 |
7 other study(ies) available for adamantane and Cognitive Dysfunction
| Article | Year |
|---|---|
The novel adamantane derivatives as potential mediators of inflammation and neural plasticity in diabetes mice with cognitive impairment.
Topics: Adamantane; Animals; Brain-Derived Neurotrophic Factor; Cognitive Dysfunction; Diabetes Mellitus; Dipeptidyl-Peptidase IV Inhibitors; Dopamine Agents; Humans; Inflammation; Inflammation Mediators; Mice; Neuronal Plasticity | 2022 |
[
Topics: Adamantane; Alzheimer Disease; Amyloid beta-Peptides; Animals; Brain; Cognitive Dysfunction; Histone Deacetylase 1; Histone Deacetylases; Humans; Hydroxamic Acids; Positron-Emission Tomography; Rats; tau Proteins | 2022 |
Adamantanes might be protective from COVID-19 in patients with neurological diseases: multiple sclerosis, parkinsonism and cognitive impairment.
Topics: Adamantane; Adult; Aged; Aged, 80 and over; Amantadine; Asymptomatic Infections; Betacoronavirus; Cognitive Dysfunction; Coronavirus Infections; COVID-19; Dopamine Agents; Female; Humans; Male; Memantine; Middle Aged; Multiple Sclerosis; Pandemics; Parkinson Disease; Pneumonia, Viral; Protective Factors; SARS-CoV-2; Severity of Illness Index | 2020 |
Neurotensin receptor 1 agonist provides neuroprotection in pre-diabetic rats.
Topics: Adamantane; Animals; Cognitive Dysfunction; Diet, High-Fat; Drug Evaluation, Preclinical; Drug Therapy, Combination; Hippocampus; Ileum; Imidazoles; Insulin Resistance; Male; Neuronal Plasticity; Obesity; Oligopeptides; Oxidative Stress; Prediabetic State; Random Allocation; Rats, Wistar; Receptors, Neurotensin | 2021 |
Neurotrophic Treatment Initiated During Early Postnatal Development Prevents the Alzheimer-Like Behavior and Synaptic Dysfunction.
Topics: Adamantane; Alzheimer Disease; Animals; Cognition; Cognitive Dysfunction; Disease Models, Animal; Early Medical Intervention; Maze Learning; Mice; Mice, Transgenic; Nerve Growth Factors; Neuronal Plasticity; Oligopeptides; Postpartum Period; Signal Transduction; Treatment Outcome | 2021 |
Vildagliptin prevents cognitive deficits and neuronal apoptosis in a rat model of Alzheimer's disease.
Topics: Adamantane; Alzheimer Disease; Amyloid beta-Peptides; Animals; bcl-2-Associated X Protein; Caspase 3; Cognitive Dysfunction; Disease Models, Animal; Disks Large Homolog 4 Protein; Gene Expression Regulation; Glycogen Synthase Kinase 3 beta; Hippocampus; Injections, Intraventricular; Male; Maze Learning; Neurons; Neuroprotective Agents; Nitriles; Nootropic Agents; Peptide Fragments; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; Pyrrolidines; Rats; Rats, Sprague-Dawley; Signal Transduction; Synaptophysin; tau Proteins; Vildagliptin | 2018 |
FGF21 and DPP-4 inhibitor equally prevents cognitive decline in obese rats.
Topics: Adamantane; Animals; Apoptosis; Cognitive Dysfunction; Dipeptidyl-Peptidase IV Inhibitors; Fibroblast Growth Factors; Hippocampus; Humans; Insulin Resistance; Male; Malondialdehyde; Mitochondria; Neuronal Plasticity; Nitriles; Obesity; Oxidative Stress; Pyrrolidines; Rats, Wistar; Signal Transduction; Vildagliptin | 2018 |